Theorem Clinical Research
Theorem Clinical Research Inc. is a leading midsized provider of comprehensive clinical research and development services with offices in more than 30 countries and a customer base comprised of some of the world’s leading pharmaceutical, biotech and medical device companies.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.
Uniphar
Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.
Company Details
Latest Content from PMHub
Video: Patient level prescribing decisions
White Papers and Resources | February 9, 2016 | Inizio
Quantitative Director Duncan Munro explores the benefits of using patient level prescribing decisions.There is no “one size fits all” approach to conducting demand assessments. The best studies utilise a methodology...
Pharma Market Research Report – Predictions for 2016
White Papers and Resources | February 9, 2016 | Inizio
PMR invited US President Harriet Kozak to submit her predictions for 2016
Pharmaceutical Market Research Conference 2016
White Papers and Resources | February 9, 2016 | Inizio
Research Partnership exhibited and presented a paper at the Pharmaceutical Market Research Conference last week in Parsippany, NJ.Representing Research Partnership were US President Harriet Kozak and Director Phil Rosenberg.Harriet presented the paper...
Nicole Bender Moreira promoted to Associate Director, Singapore office
White Papers and Resources | February 9, 2016 | Inizio
Research Partnership is delighted to announce the promotion of Nicole Bender Moreira to Associate Director in recognition of the contribution she has made to the growing success of our Singapore...
New appointments announced across Research Partnership’s global offices
White Papers and Resources | February 9, 2016 | Inizio
We are delighted to welcome Marianne Jaeger as Associate Director to our London headquarters
What to Consider When Conducting Patient Research in Saudi Arabia
White Papers and Resources | February 9, 2016 | Inizio
The need to understand the patient as a key stakeholder is now recognized by pharma across the globe.
Research Partnership hires Graphic Designer to create storytelling deliverables
White Papers and Resources | February 9, 2016 | Inizio
Research Partnership has extended its healthcare research and consulting offering to include storytelling deliverables with the hire of multi-media graphic designer Amanda Brent at the company’s London headquarters. Working with...
I want to ride my bicycle, I want to ride my bike!
White Papers and Resources | February 9, 2016 | Say Communications
Our team’s motivations behind cycling on two static bikes for 282 miles - the equivalent of London to Paris, to raise money for British Dupuytren’s Society. Please donate!
A Lucid Induction
Press Releases | February 5, 2016 | Lucid Group Communications Limited
Lucid Group kick off 2016 with six new employees
What pharma needs to know about genomic data in 2016
White Papers and Resources | February 3, 2016 | Blue Latitude Health
Consultant David Cooney from Blue Latitude Health talks us through what this progress in genomics means for pharma in 2016.